GENMAB AS DK 1 | 273.00 / -2.60% |
Date/Time | 03/03 / 12:12 |
Chg. / Chg.(%) | -7.30 / -2.60% |
Bid | 273.00 |
Ask | 273.70 |
Open | 280.30 |
Previous Close | 280.30 |
High | 281.30 |
Low | 273.00 |
Volume [EUR] | - |
Volume [Units] | |
Price fixings | 2043 |
ISIN | DK0010272202 |
Security | GE9 |
Exchange | Lang & Schwarz |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Cboe Europe .. | 2,034.00 | ![]() |
25,884 |
Turquoise | 2,034.00 | ![]() |
6,564 |
London Inter.. | 2,036.0 | ![]() |
3,066 |
Cboe Europe .. | 2,043.50 | ![]() |
146 |
TradeGate | 272.500 | ![]() |
82 |
Cboe Europe .. | 2,045.00 | ![]() |
65 |
Frankfurt | 275.2000 | ![]() |
12 |
gettex | 272.600 | ![]() |
3 |
Vienna Globa.. | 278.20 | ![]() |
0 |
München | 284.70 | ![]() |
0 |
Düsseldorf | 273.50 | ![]() |
0 |
Berlin | 274.00 | ![]() |
0 |
Lang & Schwa.. | 273.00 | ![]() |
|
Stuttgart | 274.800 | ![]() |
|
OMX Nordic | 2,102.00 | ![]() |
189,102 |
Nasdaq Other.. | 338.2800 | ![]() |
372 |
Mexico | 7,638.15 | ![]() |
11,330 |
News
- Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
02/25/2021 / 20:53 - GlobeNewswire - Genmab announces initiation of share buy-back program
02/23/2021 / 17:05 - GlobeNewswire - Genmab Publishes 2020 Annual Report
02/23/2021 / 17:00 - GlobeNewswire - Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
02/22/2021 / 14:00 - GlobeNewswire - Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer
02/10/2021 / 22:05 - GlobeNewswire